Uniqure NV (QURE) Ownership

26.03 ↓0.26 (-0.99%)
As of Market Close on December 2nd, 2022.

Institutional Ownership

Point72 Asset Management, L.P. is the biggest individual institutional holder of Uniqure NV (QURE), owning a total of 3.8 million shares. Combined, the top 20 institutional holders of QURE own 54.80% of the company with a total of 25.7 million shares.

In the latest ownership report on September 30th 2022, the top 20 institutional holders increased their combined ownership of QURE by 1 million shares. 5 institutions bought 1,155,654 total additional shares and increased their ownership by an average of 32.16%. However 1 institutions sold 130,019 total shares and decreased their ownership by an average of 13.38%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Uniqure NV increased by a net total of 1,025,635 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
State Street Corporation6.543%29.517%3,063,265698,1212022-09-30
Vanguard Group Inc3.063%10.938%1,434,004141,3822022-09-30
683 Capital Management LLC2.934%1.373%1,373,60018,6002022-09-30
Aquilo Capital Management, LLC1.797%-13.384%841,471-130,0192022-09-30
Tekla Capital Management LLC1.114%0.000%521,69302022-09-30
Goldman Sachs Group Inc1.005%16.765%470,48267,5512022-09-30
Adage Capital Partners Gp LLC0.972%102.222%455,000230,0002022-09-30

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Point72 Asset Management, L.P.8.159%17.518%3,819,700569,4002022-06-30
Nantahala Capital Management, LLC6.602%9.934%3,090,757279,2982022-06-30
State Street Corporation6.543%29.517%3,063,265698,1212022-09-30
FMR Inc5.953%-26.540%2,786,683-1,006,7812022-06-30
Partner Fund Management LP4.777%318.307%2,236,3701,701,7462022-06-30
Vanguard Group Inc3.063%10.938%1,434,004141,3822022-09-30
683 Capital Management LLC2.934%1.373%1,373,60018,6002022-09-30
Orbimed Advisors, LLC1.869%-4.830%874,849-44,4002022-06-30
Aquilo Capital Management, LLC1.797%-13.384%841,471-130,0192022-09-30
JPMorgan Chase & Co1.717%-9.172%803,669-81,1512022-06-30
Balyasny Asset Management LLC1.524%191.729%713,240468,7532022-06-30
Holocene Advisors, LP1.454%0.000%680,653680,6532022-06-30
Marshall Wace Asset Management Ltd1.210%0.000%566,645566,6452022-06-30
Tekla Capital Management LLC1.114%0.000%521,69302022-09-30
AllianceBernstein L.P.1.079%54.288%505,156177,7452022-06-30
Ameriprise Financial Inc1.024%-1.717%479,248-8,3712022-06-30
T. Rowe Price Associates, Inc.1.017%44.079%475,917145,6002022-06-30
Goldman Sachs Group Inc1.005%16.765%470,48267,5512022-09-30
Privium Fund Management B.V.0.986%-6.415%461,589-31,6402022-06-30
Adage Capital Partners Gp LLC0.972%102.222%455,000230,0002022-09-30

Mutual Fund Ownership

iShares Core S&P Small-Cap ETF is the biggest individual fund holder of Uniqure NV (QURE), owning a total of 3 million shares. Combined, the top 20 mutual fund holders of QURE own 29.76% of the company with a total of 13.9 million shares.

In the latest ownership report on October 31st 2022, the top 20 fund holders increased their combined ownership of QURE by 27 thousand shares. 4 funds bought 32,750 total additional shares and increased their ownership by an average of 0.58%. However 1 funds sold 5,796 total shares and decreased their ownership by an average of 0.88%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Uniqure NV increased by a net total of 26,954 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
iShares Core S&P Small-Cap ETF6.494%0.278%3,040,2868,4392022-10-31
SPDR® S&P Biotech ETF5.294%0.726%2,478,40017,8622022-10-31
JPM Thematics Genetic Thrps C2 Acc USD1.393%-0.881%651,942-5,7962022-10-31
Vanguard Extended Market Index Investor1.253%0.848%586,6404,9312022-10-31
iShares S&P Small-Cap 600 Growth ETF1.105%0.000%517,24302022-10-31
Vanguard Tax-Managed Small Cap Adm0.843%0.000%394,69902022-10-31
iShares Biotechnology ETF0.679%0.480%317,7801,5182022-10-31
Direxion Daily S&P Biotech Bull 3X ETF0.483%0.000%226,32302022-10-31
SPDR® S&P 600 Small Cap Growth ETF0.469%0.000%219,34002022-10-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
iShares Core S&P Small-Cap ETF6.494%0.278%3,040,2868,4392022-10-31
SPDR® S&P Biotech ETF5.294%0.726%2,478,40017,8622022-10-31
Worldwide Healthcare Ord2.412%36.874%1,129,000304,1512022-07-31
Delaware Healthcare I1.508%0.000%706,16602022-09-30
Fidelity® Select Health Care1.431%0.000%670,00002022-09-30
JPM Thematics Genetic Thrps C2 Acc USD1.393%-0.881%651,942-5,7962022-10-31
Vanguard Extended Market Index Investor1.253%0.848%586,6404,9312022-10-31
International Biotechnology Ord1.163%21.949%544,50098,0002022-09-30
iShares S&P Small-Cap 600 Growth ETF1.105%0.000%517,24302022-10-31
Biotech Growth Ord1.000%0.000%468,000468,0002022-07-31
Fidelity Advisor® Health Care I0.940%0.000%440,00002022-09-30
Fidelity Growth Compy Commingled Pl 30.920%0.189%430,8908112022-09-30
Vanguard Tax-Managed Small Cap Adm0.843%0.000%394,69902022-10-31
Tekla Healthcare Investors0.763%0.000%357,08002022-06-30
iShares Biotechnology ETF0.679%0.480%317,7801,5182022-10-31
Fidelity® Growth Company0.606%0.000%283,52702022-09-30
Fidelity® Select Biotechnology0.546%0.000%255,60802022-09-30
Direxion Daily S&P Biotech Bull 3X ETF0.483%0.000%226,32302022-10-31
SPDR® S&P 600 Small Cap Growth ETF0.469%0.000%219,34002022-10-31
Jupiter Merian Glb Eq AbsRet I USD Acc0.458%0.000%214,167214,1672022-06-30

Discussions

Please log in or register to share your thoughts.

bettysburgers

$QURE we all speculate but nobody knows what going to happen.

0 Like Report
SayMyName

$QURE Silly Bears tricks are for kids

0 Like Report
a

$QURE Who’s still buying calls?

0 Like Report
Clean_Teoth

$QURE day trade is ok to buy here but sell later

0 Like Report